(Q43698942)

English

Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer

scientific article published in August 2001

Statements

Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer (English)
1 August 2001
2396-2404

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit